Intercept Pharma’s new liver disease drug comes with hefty price tag: $70,000 a year By: MarketWatch May 31, 2016 at 13:19 PM EDT The company says it’s still cheaper than a liver transplant. Read More >> Related Stocks: Intercept Pharmaceuticals